Identifies specific amino acid residues (Thr-1066 and Gln-1070 or Asp-955) in the IIIS5 segment of L-type calcium channels that form a crucial binding motif for 1,4-dihydropyridine sensitivity.
Answers are grounded in this paper and cite their sources.
Does not support clinical changes; leaves open targeted DHP design via channel residue mapping.
The transmembrane segment IIIS5 of the L-type calcium channel alpha1 subunit participates in the formation of the 1,4-dihydropyridine (DHP) interaction domain (Grabner, M., Wang, Z., Hering, S., Striessnig, J., and Glossmann, H. (1996) Neuron 16, 207-218). We applied mutational analysis to identify amino acid residues within this segment that contribute to DHP sensitivity. DHP agonist and antagonist modulation of Ba2+ inward currents was assessed after coexpression of chimeric and mutant calcium channel alpha1 subunits with alpha2delta and beta1a subunits in Xenopus oocytes. Whereas DHP antagonists required Thr-1066, DHP agonist modulation crucially depended on the additional presence of Gln-1070 (numbering according to alpha1C-a), which also further increased the sensitivity to DHP antagonists. Asp-955, which is found at the corresponding position in the calcium channel alpha1S subunit from carp skeletal muscle, displayed functional similarity to Gln-1070 with respect to DHP interaction. We conclude that these residues (Thr-1066 plus Gln-1070 or Asp-955), which are located in close vicinity on the same side of the putative alpha-helix of transmembrane segment IIIS5, form a crucial DHP binding motif.
No takes yet. Share an insight, caveat, or question.
Mitterdorfer et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: